INOVIO PHARMACEUTICALS, INC. Current Liabilities
INOVIO PHARMACEUTICALS, INC. (INO) had Current Liabilities of $39.92 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-12
- 2026-06-30: Liabilities, Current $39.92M.
- 2026-03-31: Liabilities, Current $37.92M.
- 2025-12-31: Liabilities, Current $43.67M.
- 2025-09-30: Liabilities, Current $69.82M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $39.92M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $37.92M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $43.67M 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $69.82M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $31.71M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $27.33M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $35.33M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $23.50M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $26.40M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $23.40M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $42.57M 10-K · filed 2025-03-18 | |
| 2023-09-30 | $43.71M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $51.93M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $55.15M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $96.87M 10-K · filed 2024-03-06 | |
| 2022-09-30 | $94.91M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $131.06M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $59.36M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $65.74M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $51.38M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $51.75M 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $41.54M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $41.71M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $41.26M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $37.98M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $32.29M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $31.99M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $19.55M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $24.08M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $27.42M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $35.30M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $28.00M 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $28.41M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $51.38M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $35.41M 10-K · filed 2019-03-12 | |
| 2017-09-30 | $33.36M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $27.38M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $40.00M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $43.82M 10-K · filed 2018-03-14 | |
| 2016-09-30 | $41.37M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $35.49M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $33.40M 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $31.47M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $18.28M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $14.52M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $8.16M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $14.09M 10-K · filed 2016-03-14 | $14.02M 10-K · filed 2015-03-16 |
| 2014-09-30 | $8.93M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $11.60M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $15.64M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $28.97M 10-K · filed 2015-03-16 | |
| 2013-09-30 | $20.44M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $19.07M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $15.98M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $8.38M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $11.28M 10-Q · filed 2012-11-07 | |
| 2012-06-30 | $10.23M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $13.01M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $11.04M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $9.70M 10-Q · filed 2011-11-07 | |
| 2011-06-30 | $9.94M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $6.44M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |